Figure 8.
MET receptor activation (A), the promotion of cell motility (B), and the induction of tubulogenesis (C) by HGF and synthetic MET agonists by cyclic peptides [25]. The MET activation, cell motility, and tubulogenesis were analyzed using human mesothelioma cells (A) or normal human renal tubular cells (B,C). Scale bar, 400 μm.